At our core, we are a genome engineering company that is determined to use a wide range of gene editing tools to push the boundaries of science for the field of transplantation.
We believe next-generation gene editing tools can address a fundamental and global need for access to a greater number of human-compatible organs.
Leveraging our platform, we’ve been able to address previously unbeatable biological hurdles in the transplantation field.
Our approach is to address both infectious disease risk as well as molecular incompatibilities between species in order to develop safe and durable xeno organs for human transplantation.
Are you interested in how we’re applying our gene editing technology?